Gaba Therapeutics

0 followers


GABA Therapeutics is developing GRX-917 for anxiety and depression, with fast onset, minimal side effects and is non-addictive.

Industries

Employees

11-50

Links


Org chart

Curt Scribner
MD, Regulatory

Board & advisors

Ryan Barrett
Chairman of the Board
Dennis E. Burns
Business Advisor
H. Christian Fibiger
Independent Director
Alan F. Schatzberg
Scientific Advisory Board Member
Michael E. Thase
Scientific Advisory Board Member
Roberta Diaz Brinton
Scientific Advisory Board Member
Vassilios Papadopoulos
Scientific Advisory Board Member
Kelvin Gee
Scientific Advisory Board Member